000124071 001__ 124071
000124071 005__ 20240319081030.0
000124071 0247_ $$2doi$$a10.5114/ada.2022.114885
000124071 0248_ $$2sideral$$a132538
000124071 037__ $$aART-2022-132538
000124071 041__ $$aeng
000124071 100__ $$aKrajewski, Piotr
000124071 245__ $$aHidradenitis Suppurativa Quality of Life 24 (HSQoL-24)now available for Polish patients: creation and validationof the Polish language version
000124071 260__ $$c2022
000124071 5060_ $$aAccess copy available to the general public$$fUnrestricted
000124071 5203_ $$aIntroduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disorder with a well-documented impact on quality of life (QoL). Due to the very distinctive features of HS the clinical picture, and lack of specific questions, generic dermatology QoL questionnaires cannot adequately reflect patients’ suffering.
Aim: To translate and validate the Polish version of the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire.
Material and methods: The standardized translation process included forward and backward translation from the English version of the instrument. The final version was subsequently validated on a group of 30 HS patients, who
completed the questionnaire twice. Internal consistency, test-retest reliability, and reproducibility of the results were also analysed.
Results: The Polish version of HSQoL-24 showed excellent internal consistency, with a Cronbach α coefficient of 0.908. Moreover, excellent reproducibility of the results was observed, with an intraclass correlation coefficient of 0.908. The HSQoL global score correlated positively with Dermatology Life Quality Index (DLQI) and Hidradenitis Suppurativa Quality of Life (HiSQoL) questionnaire.
Conclusions: The Polish version of HSQoL-24 has excellent internal consistency, good reproducibility, and adequate validity. It may be of help in assessing QoL impairment in HS patients in daily practice and research.
000124071 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-sa$$uhttp://creativecommons.org/licenses/by-nc-sa/3.0/es/
000124071 590__ $$a1.4$$b2022
000124071 592__ $$a0.384$$b2022
000124071 591__ $$aDERMATOLOGY$$b59 / 70 = 0.843$$c2022$$dQ4$$eT3
000124071 593__ $$aImmunology and Allergy$$c2022$$dQ3
000124071 591__ $$aALLERGY$$b25 / 28 = 0.893$$c2022$$dQ4$$eT3
000124071 593__ $$aDermatology$$c2022$$dQ3
000124071 594__ $$a2.3$$b2022
000124071 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000124071 700__ $$aBardowska, Klaudia
000124071 700__ $$aMatusiak, Lukasz
000124071 700__ $$aSzepietowska, Marta
000124071 700__ $$aTyczynska, Kinga
000124071 700__ $$aMarron, Servando
000124071 700__ $$0(orcid)0000-0003-1917-6906$$aAragones, Lucía
000124071 700__ $$aSzepietowski, Jacek
000124071 773__ $$g39, 6 (2022), 1053-1058$$pPostepy Dermatologii i Alergologii$$tPostepy Dermatologii i Alergologii$$x1642-395X
000124071 8564_ $$s150644$$uhttps://zaguan.unizar.es/record/124071/files/texto_completo.pdf$$yVersión publicada
000124071 8564_ $$s2185754$$uhttps://zaguan.unizar.es/record/124071/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000124071 909CO $$ooai:zaguan.unizar.es:124071$$particulos$$pdriver
000124071 951__ $$a2024-03-18-17:05:02
000124071 980__ $$aARTICLE